发明名称 |
Treatment of respiratory diseases |
摘要 |
A pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours. |
申请公布号 |
EP1449528(A1) |
申请公布日期 |
2004.08.25 |
申请号 |
EP20040011047 |
申请日期 |
2001.04.09 |
申请人 |
ARAKIS LIMITED |
发明人 |
BANNISTER, ROBIN MARK;RICHARDS, ANDREW, JOHN, MCGLASHAN;GILBERT, JULIAN CLIVE;MORTON, DAVID A.;STANIFORTH, JOHN |
分类号 |
A61K9/72;A61K9/00;A61K9/12;A61K9/14;A61K9/16;A61K31/00;A61K31/40;A61K31/4015;A61K31/46;A61K38/00;A61K45/00;A61K45/06;A61K47/12;A61K47/36;A61L9/04;A61P11/06;A61P35/00;A61P43/00 |
主分类号 |
A61K9/72 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|